cognitive decline

May 23, 2018May 23, 2018

Janssen Halts Clinical Development of Alzheimer’s Candidate Atabecestat Due to Liver Issues

News

Janssen pulled the plug on a Phase 2b/3 trial and a Phase 2 safety study of its Alzheimer’s disease experimental therapy atabecestat due to toxicity issues as a result of ... Read more

July 12, 2017

Strawberry Compound Fisetin Slows Cognitive Decline of Aging in Mouse Study

News

Researchers fed the antioxidant fisetin, found in strawberries and other fruits and vegetables, to mice for seven months and found that the compound partially protected the animals from age-associated cognitive ... Read more

April 10, 2017April 10, 2017

In Senate Testimony, AFA Urges More Federal Funding for Alzheimer’s Research

News

The Alzheimer’s Foundation of America (AFA), which represents more than 2,600 member organizations nationwide, testified March 29 at a Senate hearing in Washington that discussed issues related to cognitive decline. The ... Read more

April 5, 2017April 5, 2017

Study on Slower Brain Volume Loss in SuperAgers May Shed Light on Alzheimer’s, Other Dementias

News

So-called “SuperAgers” lose brain volume more slowly than their normally aging peers, protecting them from dementia, according to a new study that proves yet again that Alzheimer’s disease — like other dementias ... Read more

February 8, 2017

Alzheimer’s Onset and Progression May Be Linked to Subclinical Epileptic Activity

News

Epileptic activity appear to be more frequent in patients with Alzheimer’s disease than in healthy individuals and may be linked to disease progression, according to a recent study. These findings, ... Read more

February 1, 2017February 1, 2017

As Glucose Levels Fall in the Brain, Series of Molecular Reactions Seen to Kill Neurons

News

Low glucose levels in the brain are known to lead memory problems and cognitive decline, and new research suggests they do so by triggering a series of molecular reactions that ultimately kill neurons. ... Read more

November 22, 2016December 6, 2016

Anavex’s Experimental Alzheimer’s Treatment Prevents Mental-acuity Decline in Clinical Trial

News

Anavex Life Sciences reported that its experimental drug Anavex 2-73 prevented further decline in mental capacity in a small Phase 2a trial involving 32 patients with mild to moderate Alzheimer’s disease. Although ... Read more

July 29, 2016July 29, 2016

Cognitive Decline in Mild Alzheimer’s Slowed with Azeliragon

News

Data from a Phase 2b clinical trial showing that vTv Therapeutics‘s investigational drug, azeliragon, slows cognitive decline in patients with mild Alzheimer’s disease were presented at the Alzheimer’s Association International Conference ... Read more

July 22, 2016July 22, 2016

Pilot Study on MEND for Cognitive Decline to Be Presented at AAIC 2016

News

North Carolina-based Muses Labs will show its latest technology and services July 24-28 at the Alzheimer’s Association International Conference (AAIC) 2016 in Toronto, Canada. Expected to spur most interest is a presentation ... Read more

July 15, 2016July 15, 2016

Metabolon and Muses Lab Partner to Advance Platform for Treatment of Early Alzheimer’s

News

Muses Labs and Metabolon announced they have entered into a partnership to assess the application of metabolomics in people with early symptoms of cognitive decline and Alzheimer’s disease (AD). Metabolomics ... Read more

Pin It on Pinterest